Investigating how RNA processing affects brain function in myotonic dystrophy
Official title: RNA Processing-Mediated Mechanisms of CNS Dysfunction in Myotonic Dystrophy
Funded at University of Florida · NIH-10852078 · Data updated 2026-11-12
This study is looking at how problems with RNA processing in the brain can affect people with myotonic dystrophy, and it hopes to find new ways to help improve brain function for those living with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | July 1, 2019 |
| Project end | June 30, 2025 |
| Funding year | 2023 |
| Award (this year) | $72,864 |
| NIH project number | 3R01NS112291-05S1 |
| Project ID | NIH-10852078 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with myotonic dystrophy, particularly those experiencing cognitive or neurological symptoms.
✕Less likely to help
Patients without myotonic dystrophy or those who do not exhibit CNS-related symptoms may not benefit from this research.
What this research studies
This research focuses on understanding the mechanisms by which RNA processing contributes to brain dysfunction in individuals with myotonic dystrophy, a genetic condition that affects various body tissues. The study utilizes both animal models and human postmortem tissue to explore how specific RNA processing defects lead to cognitive and neurological impairments. By examining the role of Muscleblind (MBNL) proteins in regulating RNA splicing, the researchers aim to identify potential therapeutic strategies that could restore normal brain function. Patients may benefit from insights that could lead to new treatments targeting the underlying RNA mechanisms.
Why it matters
Potential benefit: If successful, this research could lead to novel therapies that improve brain function and quality of life for patients with myotonic dystrophy.
How similar studies have gone: Previous research has shown promising results in understanding RNA-mediated mechanisms in other genetic conditions, suggesting potential for success in this area as well.
Where this research is happening
-
University of Florida
Gainesville, United States Active
Researchers
- Principal investigator: Wang, Eric T — University of Florida
- Study coordinator: Wang, Eric T
Related research
Other NIH-funded projects on the same topics.
-
New small molecule therapeutics to help myotonic dystrophy
A new NIH-funded project tests specially designed small molecules to lower harmful RNA activity in myotonic dystrophy and related diseases, aiming to reduce disease-driving RNA effects.
-
Mechanisms of muscle disease in myotonic dystrophy type 1
This project looks at why skeletal muscles weaken and waste away in adults with myotonic dystrophy type 1 and aims to uncover the underlying molecular causes.
-
Extracellular vesicle biomarkers to monitor DM1 using urine and blood samples
A study looking for easy, noninvasive biomarkers in urine and blood to track disease activity in people with myotonic dystrophy type 1.
-
Calcium Channel Blocker in DM1: Can amlodipine help myotonic dystrophy type 1
This study tests whether the calcium‑channel blocker amlodipine can improve symptoms and survival in myotonic dystrophy type 1 (DM1).
-
Preparing therapies for DM1 across ages, with a focus on children
A broad, patient-focused effort to bring promising DM1 therapies to both children and adults by enriching trial readiness, biomarkers, and natural history data.
-
Biological factors that drive variability in myotonic dystrophy
This grant explores why myotonic dystrophy can look very different from person to person by studying its genetic changes and how they affect muscle in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.